Loading asset research
Corbus Pharmaceuticals Holdings Inc. Common Stock
CRBPNasdaq · USD · StocksQuote as of · Exchange session not verified$7.45
-3.75%
Today
CRBP
Loading 1D prices…
Market cap
$137.2M
Volume
757.8K
52w high
$20.5652w low
$6.32Company profile
Corbus Pharmaceuticals Holdings Inc. Common Stock
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
NORWOOD, MA, United States
Employees
36
Fiscal year end
1231
CIK
1595097
Session & valuation
Open$7.69
Previous close$7.74
Day high$7.76
Day low$7.13
30-day avg. volume1.1M
Outstanding shares19.3M
Diluted EPS-$5.90
Latest annual period
P/E (trailing)-1.26
P/E (forward)-1.29
Price / book1.30
Beta2.64
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| SPRBSpruce Biosciences Inc. Common Stock | $136.6M | $0.00 | — | -$50.83 | -0.80% | Buy |
| KRROKorro Bio Inc. Common Stock | $139.9M | $6.4M | -1834.48% | -$12.48 | -2.29% | Buy |
| RNAAtrium Therapeutics Inc. Common Stock | $142.1M | $18.6M | -411.88% | -$2.89 | -0.18% | Buy |
| HURATuHURA Biosciences Inc. Common Stock | $131.3M | $0.00 | — | -$0.63 | +2.44% | Buy |
| TLSATiziana Life Sciences Ltd. Common Shares | $130.4M | $0.00 | — | -$0.16 | -0.95% | Buy |